Opexa Therapeutics Inc (OPXA.PH)

OPXA.PH on Philadelphia Stock Exchange

1.60USD
28 Jul 2014
Price Change (% chg)

$-0.08 (-4.76%)
Prev Close
$1.68
Open
$1.60
Day's High
$1.60
Day's Low
$1.60
Volume
200
Avg. Vol
--
52-wk High
--
52-wk Low
--

OPXA.PH

Chart for OPXA.PH

About

Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in developing personalized cellular therapies with the potential to treat illnesses, including multiple sclerosis (MS). These therapies are based on its T-cell technology. The Company’s core product candidate, Tovaxin, is a personalized... (more)

Overall

Beta: 2.81
Market Cap (Mil.): $44.26
Shares Outstanding (Mil.): 27.66
Dividend: --
Yield (%): --

Financials

  OPXA.PH Industry Sector
P/E (TTM): -- 103.84 36.07
EPS (TTM): -1.06 -- --
ROI: -118.91 -0.24 18.18
ROE: -150.88 -1.24 19.05
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF80.00 +0.60
Bayer AG (BAYGn.DE) €99.48 +0.19
Bayer AG (BAYE.F) -- --
Teva Pharmaceutical Industries Limited (TEVA.TA) 18,700.00₪ +80.00
Merck KGaA (MRCG.DE) €65.57 +0.36
Biogen Idec Inc (BIIB.OQ) $341.95 +5.56

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks